Case report: First case of pemetrexed plus cisplatin-induced immune hemolytic anemia in a patient with lung adenocarcinoma

BACKGROUND: Drug-induced immune hemolytic anemia (DIIHA) is a rare but potentially life-threatening drug-related complication. There are no previous reports of pemetrexed plus cisplatin as first-line chemotherapy for non-small cell lung cancer, resulting in DIIHA. CASE PRESENTATION: In this report,...

Descripción completa

Detalles Bibliográficos
Autores principales: Lu, Hongkai, Wang, Na, Wang, Peng, Zhang, Haolin, Zhao, Ru, Liu, Hongju, He, Xirong, Liu, Zeya, Chang, Yue, Cao, Yongtong, Wang, Shiyao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9452692/
https://www.ncbi.nlm.nih.gov/pubmed/36091696
http://dx.doi.org/10.3389/fmed.2022.917485

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9452692/
https://www.ncbi.nlm.nih.gov/pubmed/36091696
http://dx.doi.org/10.3389/fmed.2022.917485

Ejemplares similares